Principales conclusions et analyse des parts de marché des thérapies à base d'oligonucléotides d'ici 2025-2031
Oligonucleotide-based Therapies Market Report Analysis
Oligonucleotide-based Therapies Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- PCI Biotech
- SomaGenics
- InteRNA Technologies
- Frontiers
- miRagen Therapeutics, Inc.
- Ionis Pharmaceuticals, Inc.
- Aligos Therapeutics
- Gilead Sciences, Inc.
- Biogen Inc.
Regional Overview
- Amérique du Nord
- Europe
- Asie-Pacifique
- Amérique du Sud et centrale
- Moyen-Orient et Afrique
Market Segmentation
By Type
- Antisens
- Ribozymes
- Aptamères
- Mirna
- CPG/Immunostimulatoire
- ARNi.
By Application
- Maladies infectieuses
- oncologie
- troubles neurodégénératifs
- maladies cardiovasculaires
- maladies rénales
- autres.
By Géographie
- Amérique du Nord
- Europe
- Asie-Pacifique
- Amérique du Sud et Centrale
Get Free Sample For